Yoichi Yamamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yoichi Yamamoto has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Masao Yoshida
Department of Gastroenterology Shizuoka General Hospital Shizuoka Japan
8 shared publications - Noboru Kawata
Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
8 shared publications - Hiroyuki Ono
Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
7 shared publications Hiroyuki Ono
Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan
6 shared publications- Hiroyuki Matsubayashi
Division of Genetic Medicine Promotion Shizuoka Cancer Center Shizuoka Japan
5 shared publications - Kenichiro Imai
Division of Endoscopy Shizuoka Cancer Center Shizuoka Japan
5 shared publications
Latest Publications
- 15 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70206
Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan
Objectives: Postendoscopic submucosal dissection (ESD) bleeding remains a critical concern in patients receiving antithrombotic therapy, yet the risk after esophageal ESD is poorly characterized. This multicenter retrospective study evaluated the incidence of post‐ESD bleeding and thromboembolism in patients undergoing esophageal ESD while receiving antiplatelet therapy. Methods: We analyzed 570 patients with esophageal squamous cell carcinoma treated with ESD while on antiplatelet therapy between 2017 and 2022 at 21 institutions in Japan. Patients were categorized into guideline‐based discontinuation or continuation, excluding guideline‐deviating discontinuation. The primary endpoint was the rate of post‐ESD bleeding among thienopyridine users (monotherapy or dual antiplatelet therapy; DAPT) managed with guideline‐based discontinuation. Secondary endpoints included bleeding rates according to antiplatelet regimen and thromboembolism incidence. Results: A total of 154, 41, and 375 patients received thienopyridine monotherapy, DAPT, and aspirin monotherapy, respectively. Antiplatelet therapy was continued perioperatively in 32.5%, 31.7%, and 73.1% of these groups. Post‐ESD bleeding rates were 2.3% (3/132) and 3.2% (2/63) for guideline‐based discontinuation and continuation of thienopyridine users, respectively. Bleeding rates for discontinuation vs. continuation were 0% (0/101) vs. 0.7% (2/274) for aspirin monotherapy, 1.9% (2/104) vs. 4.0% (2/50) for thienopyridine monotherapy, and 3.6% (1/28) vs. 0% (0/13) for DAPT. Thromboembolism occurred in two patients, both receiving aspirin monotherapy. Conclusions: A substantial number of patients underwent esophageal ESD while continuing antiplatelet therapy. These descriptive findings suggest a need for further evaluation of continued therapy in larger studies.
- 15 July 2026
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (7) , e70206
Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan
Objectives: Postendoscopic submucosal dissection (ESD) bleeding remains a critical concern in patients receiving antithrombotic therapy, yet the risk after esophageal ESD is poorly characterized. This multicenter retrospective study evaluated the incidence of post‐ESD bleeding and thromboembolism in patients undergoing esophageal ESD while receiving antiplatelet therapy. Methods: We analyzed 570 patients with esophageal squamous cell carcinoma treated with ESD while on antiplatelet therapy between 2017 and 2022 at 21 institutions in Japan. Patients were categorized into guideline‐based discontinuation or continuation, excluding guideline‐deviating discontinuation. The primary endpoint was the rate of post‐ESD bleeding among thienopyridine users (monotherapy or dual antiplatelet therapy; DAPT) managed with guideline‐based discontinuation. Secondary endpoints included bleeding rates according to antiplatelet regimen and thromboembolism incidence. Results: A total of 154, 41, and 375 patients received thienopyridine monotherapy, DAPT, and aspirin monotherapy, respectively. Antiplatelet therapy was continued perioperatively in 32.5%, 31.7%, and 73.1% of these groups. Post‐ESD bleeding rates were 2.3% (3/132) and 3.2% (2/63) for guideline‐based discontinuation and continuation of thienopyridine users, respectively. Bleeding rates for discontinuation vs. continuation were 0% (0/101) vs. 0.7% (2/274) for aspirin monotherapy, 1.9% (2/104) vs. 4.0% (2/50) for thienopyridine monotherapy, and 3.6% (1/28) vs. 0% (0/13) for DAPT. Thromboembolism occurred in two patients, both receiving aspirin monotherapy. Conclusions: A substantial number of patients underwent esophageal ESD while continuing antiplatelet therapy. These descriptive findings suggest a need for further evaluation of continued therapy in larger studies.
- Open Access
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E190-E191
Two-layer closure method using anchor pronged clips for endoscopic full-thickness resection
- 8 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (S 01) , E190-E191
Open AccessTwo-layer closure method using anchor pronged clips for endoscopic full-thickness resection
- Open Access
- 26 December 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (4) , 487-494
Ophthalmological Findings in Cases of Autoimmune Pancreatitis: Changes in Long-term Corticosteroid Therapy
Background and Aims: Patients with autoimmune pancreatitis (AIP) sometimes show characteristic ophthalmologic findings, such as dacryoadenitis and dry eye. However, the ocular findings in AIP patients thus far have not fully been analyzed, especially in patients treated long term with corticosteroids (CS). We aimed to study the current and previous history of ocular diseases in AIP patients and changes of the common ophthalmologic findings during the CS treatment. Methods: We retrospectively analyzed the history of ophthalmologic diseases in 105 AIP patients and further examined the changes in the ophthalmologic findings and associated factors occurring during CS treatment in 63 patients. Results: Several common ophthalmic diseases, including cataract (33.3%) and glaucoma (6.3%), were recognized in approximately one-third of the AIP patients at their initial diagnosis. Behcet uveitis was seen in the past histories of two AIP patients. During 70 months of CS treatment, exacerbation of cataract was recognized in 31.7%, and new onset of glaucoma in 7.9%. Univariate and multivariate analyses demonstrated the cumulative CS amount as a significant risk of cataract exacerbation (p<0.05) and diffuse pancreatic swelling at the initial diagnosis as a risk of Mikulicz’s disease (p<0.01). Conclusions: An ophthalmologic check at the initial diagnosis and monitoring during CS treatment is required for patients with AIP. Promising steroid-sparing agents are expected to lessen the adverse ophthalmologic events caused by CS.
- 26 December 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (4) , 487-494
Open AccessOphthalmological Findings in Cases of Autoimmune Pancreatitis: Changes in Long-term Corticosteroid Therapy
Background and Aims: Patients with autoimmune pancreatitis (AIP) sometimes show characteristic ophthalmologic findings, such as dacryoadenitis and dry eye. However, the ocular findings in AIP patients thus far have not fully been analyzed, especially in patients treated long term with corticosteroids (CS). We aimed to study the current and previous history of ocular diseases in AIP patients and changes of the common ophthalmologic findings during the CS treatment. Methods: We retrospectively analyzed the history of ophthalmologic diseases in 105 AIP patients and further examined the changes in the ophthalmologic findings and associated factors occurring during CS treatment in 63 patients. Results: Several common ophthalmic diseases, including cataract (33.3%) and glaucoma (6.3%), were recognized in approximately one-third of the AIP patients at their initial diagnosis. Behcet uveitis was seen in the past histories of two AIP patients. During 70 months of CS treatment, exacerbation of cataract was recognized in 31.7%, and new onset of glaucoma in 7.9%. Univariate and multivariate analyses demonstrated the cumulative CS amount as a significant risk of cataract exacerbation (p<0.05) and diffuse pancreatic swelling at the initial diagnosis as a risk of Mikulicz’s disease (p<0.01). Conclusions: An ophthalmologic check at the initial diagnosis and monitoring during CS treatment is required for patients with AIP. Promising steroid-sparing agents are expected to lessen the adverse ophthalmologic events caused by CS.
- 30 July 2025
- Published by Springer Nature in Gastric Cancer
- Vol. 28 (6) , 1291-1296
Early stage gastric cancer with unusual sarcomatous component and no recurrence after endoscopic submucosal dissection: a case report
Gastric cancer with sarcomatous changes is relatively rare and often detected at an advanced stage. We report the case of an 82-year-old man with early stage gastric cancer exhibiting an unusual morphology with a polypoid growth of a sarcomatous component arising from a flat area of a well-differentiated adenocarcinoma. He achieved mid-term remission after endoscopic submucosal dissection (ESD). Upon admission, upper gastrointestinal endoscopy revealed a 60-mm flat elevated lesion with a nodule; no lymph node or distant metastasis was noted. He was diagnosed with early stage gastric cancer and underwent ESD. Pathological examination of the nodule revealed carcinomatous cells transitioning to atypical spindle cells and sarcomatous changes, suggesting that the sarcomatous component originated from a gastric-type adenocarcinoma. There was no local recurrence or metastasis at 21 months post-ESD. This is the first report of a case of early stage gastric cancer with a sarcomatous change that achieved mid-term outcome after ESD.
- 30 July 2025
- Published by Springer Nature in Gastric Cancer
- Vol. 28 (6) , 1291-1296
Early stage gastric cancer with unusual sarcomatous component and no recurrence after endoscopic submucosal dissection: a case report
Gastric cancer with sarcomatous changes is relatively rare and often detected at an advanced stage. We report the case of an 82-year-old man with early stage gastric cancer exhibiting an unusual morphology with a polypoid growth of a sarcomatous component arising from a flat area of a well-differentiated adenocarcinoma. He achieved mid-term remission after endoscopic submucosal dissection (ESD). Upon admission, upper gastrointestinal endoscopy revealed a 60-mm flat elevated lesion with a nodule; no lymph node or distant metastasis was noted. He was diagnosed with early stage gastric cancer and underwent ESD. Pathological examination of the nodule revealed carcinomatous cells transitioning to atypical spindle cells and sarcomatous changes, suggesting that the sarcomatous component originated from a gastric-type adenocarcinoma. There was no local recurrence or metastasis at 21 months post-ESD. This is the first report of a case of early stage gastric cancer with a sarcomatous change that achieved mid-term outcome after ESD.
- 16 January 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (5) , 560-562
Endoscopic submucosal dissection and photodynamic therapy of residual lesions after radiotherapy for esophageal cancer
Watch a video of this article.
- 16 January 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (5) , 560-562
Endoscopic submucosal dissection and photodynamic therapy of residual lesions after radiotherapy for esophageal cancer
Watch a video of this article.
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1305-E1306
Minimally invasive retrograde esophageal endoscopic submucosal dissection via gastrostomy using a thin therapeutic endoscope
A 58-year-old woman with dysphagia was diagnosed with advanced esophageal cancer. She achieved complete response with definitive chemoradiotherapy, but cervical esophageal stenosis occurred ([Fig. 1]). A percutaneous endoscopic gastrostomy was performed for nutritional support. Endoscopic balloon dilation was performed; however, the stricture was refractory, and a standard-caliber endoscope could not pass even after dilation. After dilation, a transnasal endoscope passed through the stricture, and a superficial esophageal carcinoma (Lt/Rw, 0-IIc + IIa, cT1a-MM, 14 mm) was identified distal to the stricture ([Fig. 2]). As passage through the stricture with a standard-caliber endoscope was difficult, retrograde endoscopic submucosal dissection (ESD) via gastrostomy was planned. A thin therapeutic endoscope (EG-840TP; FUJIFILM) was inserted through the gastrostomy without dilation, and successfully provided retrograde access to the esophageal lumen ([Fig. 3]). Using an ITknife nano (OLYMPUS), ESD was performed without intraoperative complications, and en bloc resection was achieved ([Fig. 4], [Video 1]). The pathological diagnoses were as follows: squamous cell carcinoma, pT1a-MM, ly0, v0, pHM0, pVM0, and 11 × 10 mm. No local recurrence was observed at 18 months after ESD. Retrograde esophageal ESD via gastrostomy, using a standard-caliber therapeutic scope, is a valuable option for patients with difficult transoral insertion, although gastrostomy dilation was required in previous reports [1] [2]. Recent studies have also demonstrated the usefulness of thin therapeutic endoscopes in anatomically challenging situations, such as post-treatment esophageal strictures, where conventional scopes are difficult to use [3] [4] [5]. In this case, because the cervical esophageal stricture existed, the lesion was successfully resected via a retrograde approach using a thin therapeutic endoscope, and without requiring gastrostomy dilation. A thin therapeutic endoscope enables the use of standard ESD devices and eliminates the need for gastrostomy dilation, thereby simplifying the procedure. This minimally invasive approach may represent a viable therapeutic option for superficial esophageal cancer with severe esophageal strictures. Endoscopy_UCTN_Code_TTT_1AO_2AG_3AD Article published online: 19 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1305-E1306
Open AccessMinimally invasive retrograde esophageal endoscopic submucosal dissection via gastrostomy using a thin therapeutic endoscope
A 58-year-old woman with dysphagia was diagnosed with advanced esophageal cancer. She achieved complete response with definitive chemoradiotherapy, but cervical esophageal stenosis occurred ([Fig. 1]). A percutaneous endoscopic gastrostomy was performed for nutritional support. Endoscopic balloon dilation was performed; however, the stricture was refractory, and a standard-caliber endoscope could not pass even after dilation. After dilation, a transnasal endoscope passed through the stricture, and a superficial esophageal carcinoma (Lt/Rw, 0-IIc + IIa, cT1a-MM, 14 mm) was identified distal to the stricture ([Fig. 2]). As passage through the stricture with a standard-caliber endoscope was difficult, retrograde endoscopic submucosal dissection (ESD) via gastrostomy was planned. A thin therapeutic endoscope (EG-840TP; FUJIFILM) was inserted through the gastrostomy without dilation, and successfully provided retrograde access to the esophageal lumen ([Fig. 3]). Using an ITknife nano (OLYMPUS), ESD was performed without intraoperative complications, and en bloc resection was achieved ([Fig. 4], [Video 1]). The pathological diagnoses were as follows: squamous cell carcinoma, pT1a-MM, ly0, v0, pHM0, pVM0, and 11 × 10 mm. No local recurrence was observed at 18 months after ESD. Retrograde esophageal ESD via gastrostomy, using a standard-caliber therapeutic scope, is a valuable option for patients with difficult transoral insertion, although gastrostomy dilation was required in previous reports [1] [2]. Recent studies have also demonstrated the usefulness of thin therapeutic endoscopes in anatomically challenging situations, such as post-treatment esophageal strictures, where conventional scopes are difficult to use [3] [4] [5]. In this case, because the cervical esophageal stricture existed, the lesion was successfully resected via a retrograde approach using a thin therapeutic endoscope, and without requiring gastrostomy dilation. A thin therapeutic endoscope enables the use of standard ESD devices and eliminates the need for gastrostomy dilation, thereby simplifying the procedure. This minimally invasive approach may represent a viable therapeutic option for superficial esophageal cancer with severe esophageal strictures. Endoscopy_UCTN_Code_TTT_1AO_2AG_3AD Article published online: 19 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E803-E804
A case of endoscopic selective muscular dissection for calcifying fibrous tumor
A 67-year-old woman diagnosed with a gastric submucosal tumor (SMT) by esophagogastroduodenoscopy (EGD) during a medical checkup was referred to our hospital. EGD revealed a 20-mm SMT on the lesser curvature of the lower gastric body ([Fig. 1]). Endoscopic ultrasound (EUS) showed a low-echoic homogeneous lesion, which had echogenic spots with an acoustic shadow and may have been localized within the layer of the muscularis mucosa to the deep submucosa ([Fig. 2]). EUS fine-needle biopsy was performed, and a strongly suspected calcifying fibrous tumor (CFT) was detected on pathological examination; however, a definitive diagnosis could not be made. Endoscopic selective muscular dissection with en bloc resection was performed as diagnostic treatment. The SMT was diagnosed as CFT on pathological examination ([Fig. 3]). The vertical margin was negative in the area where the muscle layer was attached, whereas it was inconclusive where the muscle layer was not attached ([Fig. 4], [Video 1]). Gastric CFTs are difficult to diagnose before treatment [1]. Although gastric CFTs are typically treated surgically, endoscopic resection has been reported in some recent cases [2] [3]. Gastric CFTs can originate from all layers, but most commonly the submucosa [1]. Endoscopic submucosal dissection (ESD) may be an inadequate treatment for CFTs of the deep submucosa. Endoscopic selective muscular dissection has been reported as a new treatment strategy for cT1b gastric cancer [4]. Endoscopic selective muscular dissection is the method of dissection between the oblique and circular muscle layer, not the submucosa. In this case, the vertical margin was negative in the area where the muscle layer was attached, whereas it was inconclusive in the area where muscle layer was not attached. In endoscopic selective muscular dissection, VM0 resection may be possible if we attempt to dissect the muscular layer in the wider area. Endoscopic selective muscular dissection may be a useful treatment option for patients with CFT suspicious of being located in the deep submucosa. Endoscopy_UCTN_Code_CCL_1AB_2AD_3AB Article published online: 19 September 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E803-E804
Open AccessA case of endoscopic selective muscular dissection for calcifying fibrous tumor
A 67-year-old woman diagnosed with a gastric submucosal tumor (SMT) by esophagogastroduodenoscopy (EGD) during a medical checkup was referred to our hospital. EGD revealed a 20-mm SMT on the lesser curvature of the lower gastric body ([Fig. 1]). Endoscopic ultrasound (EUS) showed a low-echoic homogeneous lesion, which had echogenic spots with an acoustic shadow and may have been localized within the layer of the muscularis mucosa to the deep submucosa ([Fig. 2]). EUS fine-needle biopsy was performed, and a strongly suspected calcifying fibrous tumor (CFT) was detected on pathological examination; however, a definitive diagnosis could not be made. Endoscopic selective muscular dissection with en bloc resection was performed as diagnostic treatment. The SMT was diagnosed as CFT on pathological examination ([Fig. 3]). The vertical margin was negative in the area where the muscle layer was attached, whereas it was inconclusive where the muscle layer was not attached ([Fig. 4], [Video 1]). Gastric CFTs are difficult to diagnose before treatment [1]. Although gastric CFTs are typically treated surgically, endoscopic resection has been reported in some recent cases [2] [3]. Gastric CFTs can originate from all layers, but most commonly the submucosa [1]. Endoscopic submucosal dissection (ESD) may be an inadequate treatment for CFTs of the deep submucosa. Endoscopic selective muscular dissection has been reported as a new treatment strategy for cT1b gastric cancer [4]. Endoscopic selective muscular dissection is the method of dissection between the oblique and circular muscle layer, not the submucosa. In this case, the vertical margin was negative in the area where the muscle layer was attached, whereas it was inconclusive in the area where muscle layer was not attached. In endoscopic selective muscular dissection, VM0 resection may be possible if we attempt to dissect the muscular layer in the wider area. Endoscopic selective muscular dissection may be a useful treatment option for patients with CFT suspicious of being located in the deep submucosa. Endoscopy_UCTN_Code_CCL_1AB_2AD_3AB Article published online: 19 September 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 10 September 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (4) , 455-462
Investigation of vertical margin involvement in endoscopic resection for T1 colorectal cancer
Objectives: The resection of vertical margin‐negative submucosally invasive colorectal cancer (CRC) relies on the pathological risk assessment of lymph node metastasis. However, no large‐scale study has clarified the endoscopic resection (ER) outcome for submucosally invasive CRC, focusing on the vertical margin status. This retrospective study aimed to examine vertical margin involvement in ER for submucosally invasive CRC and explore the treatment consequences associated with vertical margin status.Methods: We analyzed 395 submucosally invasive CRC cases in 389 patients who underwent ER at our hospital between 2008 and 2020. The presence of residual tumors and simultaneous lymph node metastasis in patients who underwent additional surgery was assessed and compared between the vertical incomplete ER and the vertical margin‐negative groups.Results: Among the patients, 270 were men, with a median age of 69 years. The vertical incomplete ER rate was 21.5%, with positive vertical margins and unclear vertical margins identified in 12.2% and 9.3% of the cases, respectively. Among 154 patients who underwent additional surgery after ER, the vertical incomplete ER group had a significantly higher residual tumor rate than the vertical margin‐negative group (P = 0.001). The vertical incomplete ER group had a significantly higher lymph node metastasis rate than the vertical margin‐negative group (P = 0.029).Conclusion: This study clarified the substantial risk of vertical incomplete ER in submucosally invasive CRC and revealed the high risk of residual tumor and lymph node metastasis in vertical incomplete ER for submucosal CRC.
- 10 September 2023
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (4) , 455-462
Investigation of vertical margin involvement in endoscopic resection for T1 colorectal cancer
Objectives: The resection of vertical margin‐negative submucosally invasive colorectal cancer (CRC) relies on the pathological risk assessment of lymph node metastasis. However, no large‐scale study has clarified the endoscopic resection (ER) outcome for submucosally invasive CRC, focusing on the vertical margin status. This retrospective study aimed to examine vertical margin involvement in ER for submucosally invasive CRC and explore the treatment consequences associated with vertical margin status.Methods: We analyzed 395 submucosally invasive CRC cases in 389 patients who underwent ER at our hospital between 2008 and 2020. The presence of residual tumors and simultaneous lymph node metastasis in patients who underwent additional surgery was assessed and compared between the vertical incomplete ER and the vertical margin‐negative groups.Results: Among the patients, 270 were men, with a median age of 69 years. The vertical incomplete ER rate was 21.5%, with positive vertical margins and unclear vertical margins identified in 12.2% and 9.3% of the cases, respectively. Among 154 patients who underwent additional surgery after ER, the vertical incomplete ER group had a significantly higher residual tumor rate than the vertical margin‐negative group (P = 0.001). The vertical incomplete ER group had a significantly higher lymph node metastasis rate than the vertical margin‐negative group (P = 0.029).Conclusion: This study clarified the substantial risk of vertical incomplete ER in submucosally invasive CRC and revealed the high risk of residual tumor and lymph node metastasis in vertical incomplete ER for submucosal CRC.
- Open Access
- 13 July 2023
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (12) , A33-0xxxiii
Gel Immersion Endoscopic Mucosal Resection of a Gastric Hyperplastic Polyp With Adenocarcinoma
- 13 July 2023
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (12) , A33-0xxxiii
Open AccessGel Immersion Endoscopic Mucosal Resection of a Gastric Hyperplastic Polyp With Adenocarcinoma
- Open Access
Efficacy and Safety of Gel Immersion Endoscopic Mucosal Resection for Non-Pedunculated Colorectal Polyps
Underwater endoscopic mucosal resection (UEMR) has become a popular endoscopic resection method for large colorectal neoplasms. However, visualization can be poor during UEMR due to the presence of intestinal fluid. Gel immersion endoscopic mucosal resection (GIEMR), using a specially developed gel (Viscoclear®, Otsuka Pharmaceutical Factory, Tokushima, Japan), can improve the visual field. However, reports of GIEMR for colorectal polyps are limited. Herein, we evaluated the short-term outcomes of GIEMR for non-pedunculated colorectal neoplasms (NPCRN). This single-center, retrospective, and observational study includes 25 lesions in 20 patients with NPCRN who underwent GIEMR between January and October 2022. The short-term outcomes and adverse events were evaluated. The lesion locations were as follows: right colon, 18 lesions; left colon, 7 lesions; and rectum, none. The median tumor diameter was 15 (IQR, 10–18) mm. Histological classification was as follows: sessile serrated lesion, 9 cases; adenoma, 12 cases; and intramucosal adenocarcinoma, 4 cases. The overall en bloc resection rates and R0 resection rates were 80% (20/25) and 72% (18/25). For NPCRN in 10–19 mm, the en bloc resection rate was 75% (12/16), with an R0 resection rate of 69% (11/16). No post-polypectomy bleeding, perforation, or post-coagulation syndrome were observed. The findings of our study provide preliminary evidence of the efficacy and safety of GIEMR for NPCRN. Therefore, GIEMR may be a promising novel endoscopic resection method for NPCRN.
Open AccessEfficacy and Safety of Gel Immersion Endoscopic Mucosal Resection for Non-Pedunculated Colorectal Polyps
Underwater endoscopic mucosal resection (UEMR) has become a popular endoscopic resection method for large colorectal neoplasms. However, visualization can be poor during UEMR due to the presence of intestinal fluid. Gel immersion endoscopic mucosal resection (GIEMR), using a specially developed gel (Viscoclear®, Otsuka Pharmaceutical Factory, Tokushima, Japan), can improve the visual field. However, reports of GIEMR for colorectal polyps are limited. Herein, we evaluated the short-term outcomes of GIEMR for non-pedunculated colorectal neoplasms (NPCRN). This single-center, retrospective, and observational study includes 25 lesions in 20 patients with NPCRN who underwent GIEMR between January and October 2022. The short-term outcomes and adverse events were evaluated. The lesion locations were as follows: right colon, 18 lesions; left colon, 7 lesions; and rectum, none. The median tumor diameter was 15 (IQR, 10–18) mm. Histological classification was as follows: sessile serrated lesion, 9 cases; adenoma, 12 cases; and intramucosal adenocarcinoma, 4 cases. The overall en bloc resection rates and R0 resection rates were 80% (20/25) and 72% (18/25). For NPCRN in 10–19 mm, the en bloc resection rate was 75% (12/16), with an R0 resection rate of 69% (11/16). No post-polypectomy bleeding, perforation, or post-coagulation syndrome were observed. The findings of our study provide preliminary evidence of the efficacy and safety of GIEMR for NPCRN. Therefore, GIEMR may be a promising novel endoscopic resection method for NPCRN.